Zoetis
Zoetis Inc., headquartered in the United States, is a leading global animal health company dedicated to supporting the health and well-being of livestock and companion animals. Founded in 1952, Zoetis has established itself as a pioneer in the industry, focusing on the development of innovative vaccines, diagnostics, and therapeutics. With a strong presence in North America, Europe, and Asia, Zoetis offers a diverse portfolio of products that includes anti-infectives, parasiticides, and nutritional products. Their commitment to research and development has led to significant advancements in animal health, making them a trusted partner for veterinarians and farmers alike. Recognised for their market leadership, Zoetis continues to achieve notable milestones, reinforcing their position as a key player in the animal health sector.
DitchCarbon Score
How does Zoetis's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Zoetis's score of 29 is higher than 52% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Zoetis's reported carbon emissions
In 2020, Zoetis reported Scope 2 carbon emissions of approximately 222,072,000 kg CO2e. This marked an increase from 2019, when emissions were about 213,865,000 kg CO2e, and from 2018, which recorded approximately 206,154,000 kg CO2e. The company has not disclosed any Scope 1 or Scope 3 emissions data. Zoetis has set ambitious climate commitments, aiming to achieve carbon neutrality in its operations by 2030. This goal focuses on reducing Scope 1 and Scope 2 emissions from manufacturing, research and development, office locations, and fleet vehicles. Additionally, the company targets a 5% reduction in energy intensity in its manufacturing and R&D processes by 2025, using 2019 as the baseline year. These initiatives reflect Zoetis's commitment to sustainability and its proactive approach to addressing climate change within the veterinary pharmaceutical industry.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Zoetis is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
